Celecoxib and GABA Cooperatively Prevent the Progression of Pancreatic Cancer In Vitro and in Xenograft Models of Stress-Free and Stress-Exposed Mice

Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis and is associated with high levels of psychological distress. We have shown that beta-adrenergic receptors (β-ARs), which are activated by stress neurotransmitters, regulate PDAC cells via cyclic AMP (cAMP)-dependent signaling in vitro, that social stress promotes PDAC progression in mouse xenografts and that γ-aminobutyric acid (GABA) inhibits these responses in vitro and in vivo. The targeted inhibition of stress-induced regulatory pathways may abolish the potentially negative impact of psychological stress on clinical outcomes. Our current data show that chronic exposure of PDAC cell lines Panc-1 (activating point mutations in K-ras) and BXPC-3 (no mutations in K-ras) in vitro to the stress neurotransmitter epinephrine at the concentration (15 nM) previously measured in the serum of mice exposed to social stress significantly increased proliferation and migration. These responses were inhibited in a concentration-dependent manner by celecoxib. The effects of celecoxib alone and in combination with γ-aminobutyric acid (GABA) on the progression of subcutaneous mouse xenografts from the cell line (BXPC-3) most responsive to epinephrine were then investigated in the presence and absence of social stress. Cancer-stimulating factors (VEGF & prostaglandin E2 [PGE2]) and levels of cAMP were measured by immunoassays in blood and xenograft tissue. Phosphorylation of the signaling proteins ERK, CREB, Src, and AKT was assessed by ELISA assays and Western blotting. Expression of COX-2, 5-lipoxygenase, and p-5-LOX were determined by semi-quantitative Western blotting. Celecoxib alone significantly inhibited xenograft progression and decreased systemic and tumor VEGF, PGE2, and cAMP as well as phosphorylated signaling proteins in stress-exposed and stress-free mice. These responses were significantly enhanced by co-treatment with GABA. The celecoxib-induced downregulation of COX-2 protein and p-5-LOX was also significantly enhanced by GABA under both experimental conditions. Our findings identify the targeted inhibition of stress-induced pathways as a promising area for more effective cancer intervention in pancreatic cancer.

[1]  T. Adrian,et al.  Cyclooxygenases and Lipoxygenases as Potential Targets for Treatment of Pancreatic Cancer , 2001, Pancreatology.

[2]  Verena Jendrossek,et al.  Targeting apoptosis pathways by Celecoxib in cancer. , 2013, Cancer letters.

[3]  Markus F Neurath,et al.  Targeting the VEGF signaling pathway in cancer therapy , 2012, Expert opinion on therapeutic targets.

[4]  M. Tsao,et al.  The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through β-adrenergic transactivation of EGF receptors , 2005, Journal of Cancer Research and Clinical Oncology.

[5]  W. Wu,et al.  Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  G. Siegal,et al.  Signal Transduction Cross-talk During Colorectal Tumorigenesis , 2006, Advances in anatomic pathology.

[7]  R. DuBois,et al.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Steven W. Cole,et al.  Molecular Pathways: Beta-Adrenergic Signaling in Cancer , 2011, Clinical Cancer Research.

[9]  T. Adrian,et al.  Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer , 2003, Molecular Cancer.

[10]  M. Grossbard,et al.  Metastatic pancreatic cancer 2008: is the glass less empty? , 2008, The oncologist.

[11]  W. Wu,et al.  Functional Role of β-Adrenergic Receptors in the Mitogenic Action of Nicotine on Gastric Cancer Cells , 2006 .

[12]  H. Schuller,et al.  GABAB receptor is a novel drug target for pancreatic cancer , 2008, Cancer.

[13]  R. Lefkowitz The superfamily of heptahelical receptors , 2000, Nature Cell Biology.

[14]  F. Holsboer,et al.  Long-term behavioral and neuroendocrine alterations following chronic social stress in mice: Implications for stress-related disorders , 2008, Hormones and Behavior.

[15]  I. Ellis,et al.  Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival , 2010, Oncotarget.

[16]  T. Fahey,et al.  Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. , 1999, Cancer research.

[17]  H. Plummer,et al.  Social Stress Promotes and γ-Aminobutyric Acid Inhibits Tumor Growth in Mouse Models of Non–Small Cell Lung Cancer , 2011, Cancer Prevention Research.

[18]  Shadan Ali,et al.  Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy , 2005, Molecular Cancer Therapeutics.

[19]  H. Schuller Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? , 2009, Nature Reviews Cancer.

[20]  P. Philip,et al.  Defining New Paradigms for the Treatment of Pancreatic Cancer , 2011, Current treatment options in oncology.

[21]  H. S. Kim,et al.  Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  P. Maisonneuve,et al.  Risk factors for pancreatic cancer , 2005, Journal of cellular biochemistry.

[23]  Fan Zhang,et al.  Cyclooxygenase-2 is overexpressed in human cervical cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  Anil K Sood,et al.  Impact of stress on cancer metastasis. , 2010, Future oncology.

[25]  S. Lippman,et al.  Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  L. Playle,et al.  The MEK/ERK pathway mediates COX‐2‐selective NSAID‐induced apoptosis and induced COX‐2 protein expression in colorectal carcinoma cells , 2002, International journal of cancer.

[27]  M. Thun,et al.  Aspirin use and pancreatic cancer mortality in a large United States cohort. , 2004, Journal of the National Cancer Institute.

[28]  T. L. Drell,et al.  The norepinephrine‐driven metastasis development of PC‐3 human prostate cancer cells in BALB/c nude mice is inhibited by β‐blockers , 2006, International journal of cancer.

[29]  K. Kraft,et al.  Beta-endorphin and catecholamine concentrations during chronic and acute stress in intensive care patients. , 1996, European journal of medical research.

[30]  J. Shah,et al.  Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. , 1999, Cancer research.

[31]  H. Schuller,et al.  Pancreatic Cancer Cells and Normal Pancreatic Duct Epithelial Cells Express an Autocrine Catecholamine Loop that Is Activated by Nicotinic Acetylcholine Receptors α3, α5, and α7 , 2011, Molecular Cancer Research.

[32]  A. Sahin,et al.  Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. , 2002, Cancer research.

[33]  H. Plummer,et al.  The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. , 1999, Cancer research.

[34]  H. Plummer,et al.  Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention. , 2012, Carcinogenesis.

[35]  Liz Y. Han,et al.  Stress Hormone–Mediated Invasion of Ovarian Cancer Cells , 2006, Clinical Cancer Research.

[36]  H. Schuller,et al.  Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. , 2001, Carcinogenesis.

[37]  I. Ellis,et al.  Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. , 2010 .

[38]  Steven Piantadosi,et al.  The prevalence of psychological distress by cancer site , 2001, Psycho-oncology.

[39]  G. Colditz,et al.  A prospective study of aspirin use and the risk of pancreatic cancer in women. , 2004, Journal of the National Cancer Institute.

[40]  O. Werz,et al.  Arachidonic Acid Promotes Phosphorylation of 5-Lipoxygenase at Ser-271 by MAPK-activated Protein Kinase 2 (MK2)* , 2002, The Journal of Biological Chemistry.

[41]  Robert M. Sapolsky,et al.  Why zebras don't get ulcers : a guide to stress, stress related diseases, and coping , 1994 .

[42]  G. Gasparini,et al.  Pancreatic cancer: from molecular signature to target therapy. , 2008, Critical reviews in oncology/hematology.

[43]  G. Chrousos Stress and disorders of the stress system , 2009, Nature Reviews Endocrinology.

[44]  D. Tarin,et al.  Oncogenic Ras/Src cooperativity in pancreatic neoplasia , 2011, Oncogene.

[45]  Robert M. Sapolsky,et al.  Why zebras don't get ulcers : an updated guide to stress, stress-related diseases, and coping , 1994 .

[46]  H. Plummer,et al.  Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid. , 2009, Carcinogenesis.

[47]  S. Missailidis,et al.  Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. , 2009, International immunopharmacology.

[48]  M. Kay Washington,et al.  Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells* , 2001, The Journal of Biological Chemistry.

[49]  P. Unger,et al.  Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. , 2000, Urology.

[50]  K. Zänker,et al.  Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. , 2001, Cancer research.

[51]  S. Gately The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis , 2004, Cancer and Metastasis Reviews.

[52]  M. Kulke,et al.  Metastatic pancreatic cancer , 2002, Current treatment options in oncology.

[53]  A. Sood,et al.  New Directions in Reducing Stress Effects on Cancer , 2012, Cancer Prevention Research.

[54]  H. Schuller,et al.  Prevention of pancreatic cancer by the beta-blocker propranolol , 2009, Anti-cancer drugs.

[55]  A. Grothey,et al.  Cyclooxygenase-2: a novel target for cancer chemotherapy? , 2001, Journal of Cancer Research and Clinical Oncology.

[56]  R. Bold,et al.  The role of Akt activation in the response to chemotherapy in pancreatic cancer. , 2010, Anticancer research.

[57]  Liz Y. Han,et al.  Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma , 2006, Nature Medicine.